Doctor of Osteopathy Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Andrea Abousamra

Neurology Clinton Township, MI Doctor of Osteopathy

NPI 1447786520 CMS profile 4096166

15855 19 Mile Rd, Clinton Township, MI 48038

Open in the dashboard

General payments

$2,413

72 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Andrea Abousamra of Clinton Township, MI is reported in the CMS Open Payments database as having received $2,413 across 72 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 57th percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $102 4
2023 General $127 6
2022 General $378 26
2021 General $641 24
2020 General $108 1
2019 General $1,056 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrea Abousamra
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to Andrea Abousamra were reported at $0. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year Andrea Abousamra Neurology median Middle half National median
2019 $1,056 $474 $118–$2,177 $163
2020 $108 $367 $82–$2,309 $114
2021 $641 $438 $104–$2,547 $132
2022 $378 $442 $103–$2,388 $149
2023 $127 $464 $119–$2,312 $160
2024 $102 $468 $119–$2,323 $164
2025 $0 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Genentech USA, Inc. $267 2 payments
  2. AbbVie, Inc. $260 12 payments
  3. Genzyme Corporation $253 4 payments
  4. Biogen, Inc. $202 6 payments
  5. US WorldMeds, LLC $160 3 payments
  6. Alnylam Pharmaceuticals Inc. $156 2 payments
  7. Amgen Inc. $145 2 payments
  8. Alkermes, Inc. $125 1 payment
  9. Janssen Pharmaceuticals, Inc $117 10 payments
  10. SK Life Science, Inc. $108 1 payment
  11. Other $621 29 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $2,413 72 payments
Products named General payments · program years 2019–2024
  1. OCREVUS $267 2 payments
  2. APOKYN $160 3 payments
  3. ONPATTRO $156 2 payments
  4. AIMOVIG $145 2 payments
  5. BOTOX $129 6 payments
  6. ARISTADA Cns $125 1 payment
  7. ARISTADA Cns $125 1 payment
  8. ARISTADA Cns $125 1 payment
  9. ARISTADA Cns $125 1 payment
  10. ARISTADA INITIO $125 1 payment
  11. Other $1,375 63 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 16 billing codes

Paid by Medicare

$37,443

Medicare's payments for the services billed

Medicare patients

252

Average age 73

Services billed

409

150 women, 102 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 55%
Depression 50%
Diabetes 45%
Ischemic heart disease 44%
Alzheimer's or dementia 40%
Chronic kidney disease 38%
Heart failure 35%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BOTOX
  • AbbVie, Inc. $85
$85 — —
UBRELVY
  • AbbVie, Inc. $17
$17 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

72 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record